中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Cranberry Juice on Cardiovascular Risk Factors

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Penn State University
合作者
Ocean Spray Cranberries, Inc.

关键词

抽象

The purpose of this study is to evaluate the effects of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. The investigators hypothesize that the bioactive compounds in cranberry juice may elicit beneficial effects on blood pressure and arterial health, as well as LDL-C and HDL function.

描述

The investigators propose to conduct a 2-period randomized, crossover, placebo-controlled study to evaluate the effect of cranberry juice on central and peripheral blood pressure, indices of arterial stiffness, lipid and lipoprotein concentrations and size characteristics, and HDL function. Eligibility requires non-smoking men and women to be 30 to 65 years of age with BMI greater than or equal to 18 and less than or equal to 39, total cholesterol below 273 mg/dL for men and below 284 mg/dL for women, triglycerides below 350 mg/dL, and have systolic blood pressure of 120 to 159 mmHg and/or diastolic blood pressure of 80 to 99 mmHg. Subjects will undergo randomized treatments including 500 mL/d cranberry juice beverage and 500 mL/d of a color and taste matched placebo beverage. The two 8 to 12 week treatment periods will be separated by an 8 week washout.

日期

最后验证: 11/30/2019
首次提交: 09/17/2015
提交的预估入学人数: 09/20/2015
首次发布: 09/21/2015
上次提交的更新: 12/11/2019
最近更新发布: 12/12/2019
实际学习开始日期: 09/30/2015
预计主要完成日期: 04/30/2019
预计完成日期: 04/30/2019

状况或疾病

Cardiovascular Disease Risk Factors

干预/治疗

Dietary Supplement: Cranberry Juice Beverage

Dietary Supplement: Placebo Beverage

-

手臂组

干预/治疗
Experimental: Cranberry Juice Beverage
16 ounces of 54% cranberry juice cocktail
Dietary Supplement: Cranberry Juice Beverage
16 ounces of 54% cranberry juice cocktail
Placebo Comparator: Placebo Beverage
Color, calorie, and taste matched beverage without cranberry bioactives
Dietary Supplement: Placebo Beverage
Color, calorie, and taste matched beverage without cranberry bioactives

资格标准

有资格学习的年龄 30 Years 至 30 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

1. Men and women 30-65 years of age

2. BMI ≥ 18 and ≤ 39 kg/m^2

3. Total cholesterol below 273 mg/dL for men and below 284 mg/dL for women

4. Triglycerides below 350 mg/dL

5. Non-smokers

6. At least one of the following:

1. Systolic blood pressure 120-159 mmHg

2. Diastolic blood pressure 80-99 mmHg

Exclusion Criteria:

1. History of acute or chronic inflammatory conditions or heart disease, kidney disease, liver disease, autoimmune disorders, or thyroid disease (unless controlled by medication and blood results within previous 6 months are provided)

2. History of diabetes mellitus (and/or a fasting glucose >126 mg/dL at screening)

3. Stage II hypertension (blood pressure ≥ 160/100 mmHg)

4. Lactation, pregnancy, or desire to become pregnant during the study

5. Unwillingness to discontinue nutritional supplements, herbs, or vitamins unless approved by investigator

6. Use of medications/supplements for elevated lipids, blood pressure, or glucose

7. Chronic use of non-steroidal anti-inflammatory or immunosuppressant medication

8. Conditions requiring the use of steroids

9. Unwillingness to refrain from blood donation prior to and during the study

10. Any medical condition or abnormal laboratory value that is judged clinically significant by an investigator

11. Allergy or sensitivity to cranberry juice or any ingredient in the study beverages

结果

主要结果指标

1. Central Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

Aortic (central) blood pressure measured using the SphygmoCor system

2. Peripheral Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

Peripheral blood pressure measured using the SphygmoCor system

次要成果指标

1. Efflux capacity of HDL [Change from baseline after 8 week treatments with cranberry and placebo]

Ability to carry out reverse cholesterol transport measured using in vitro assay

2. Augmentation Index [Change from baseline after 8 week treatments with cranberry and placebo]

Augmentation index measured using the SphygmoCor system

3. Pulse Wave Velocity [Change from baseline after 8 week treatments with cranberry and placebo]

Pulse wave velocity measured using the SphygmoCor system

4. LDL-C [Change from baseline after 8 week treatments with cranberry and placebo]

LDL-C values calculated using the Friedewald equation

5. LDL Particle Size [Change from baseline after 8 week treatments with cranberry and placebo]

LDL particle size measured using a Vertical Auto Profile (VAP) Test

6. Total Cholesterol [Change from baseline after 8 week treatments with cranberry and placebo]

Total cholesterol values determined by enzymatic procedures

7. Triglycerides [Change from baseline after 8 week treatments with cranberry and placebo]

Triglyceride values determined using enzymatic procedures

8. HDL-C [Change from baseline after 8 week treatments with cranberry and placebo]

HDL-C will be estimated according to the modified heparin-manganese procedure

9. Oxidized LDL (oxLDL) [Change from baseline after 8 week treatments with cranberry and placebo]

Plasma concentrations of oxLDL will be measured using ELISA kits

10. Malondialdehyde (MDA) [Change from baseline after 8 week treatments with cranberry and placebo]

MDA will be measured using the thiobarbituric acid reactive substances (TBARS) assay

11. High Sensitivity C Reactive Protein (hs-CRP) [Change from baseline after 8 week treatments with cranberry and placebo]

hs-CRP will be measured by latex-enhanced immunonephelometry

12. 24-hr Ambulatory Blood Pressure [Change from baseline after 8 week treatments with cranberry and placebo]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge